Ratings on Stantec (NYSE:STN), AVEO Pharma (NASDAQ:AVEO), Limelight Networks (NASDAQ:LLNW), AnnTaylor (NYSE:ANN), Evolution Petroleum (AMEX:EPM) and Ventas (NYSE:VTR) were upgraded by analysts.
DA Davidson upgraded Stantec (STN) from a "Neutral" rating to a "Buy" rating.
MP Advisors upgraded AVEO Pharma (AVEO) from an "Underperform" rating to a "Market Perform" rating. They raised their price target on the company from $11 to $20.
Canaccord Genuity upgraded NetApp (NTAP) from a "Hold" rating to a "Buy" rating. They raised their price target on the company from $58.50 to $62.
Dougherty & Company upgraded Limelight Networks (LLNW) from a "Sell" to "Neutral." They have a price target of $5.50 on the company.
Wedbush upgraded AnnTaylor (ANN) from a "Neutral" rating to and "Outperform" rating. They increased their price from $27 to $38 on the company.
Global Hunter Securities upgraded Evolution Petroleum (EPM) from a "Neutral" rating to a "Buy" rating. They their price target from $8.50 to $12.50 on the company.
Robert W. Baird upgraded Ventas (VTR) from an "Underperform" rating to a "Neutral" rating. They raised their price target from $48 to $50 on the company.
Showing posts with label Ventas. Show all posts
Showing posts with label Ventas. Show all posts
Monday, May 16, 2011
Friday, May 13, 2011
Ratings on (NTAP) (VTR) (ENS) (WLK) Upgraded
Ratings on NetApp Inc. (NASDAQ: NTAP), Ventas (NYSE: VTR), EnerSys (NYSE: ENS) and Westlake Chemical Corp (NYSE: WLK) were upgraded by analysts.
Canaccord Genuity upgraded NetApp Inc. (NTAP) from a “hold” rating to a “buy” rating.
HSBC (NYSE:HBC) upgraded Ventas (VTR) from an “underweight” rating to a “neutral” rating. They have a price target of $50.00 on the company, up from $48.00.
Noble Financial upgraded EnerSys (ENS) from a “hold” rating to a “buy” rating.
JPMorgan Chase & Co. (NYSE:JPM) upgraded Westlake Chemical Corp (WLK) from a “neutral” rating to an “overweight” rating.
Canaccord Genuity upgraded NetApp Inc. (NTAP) from a “hold” rating to a “buy” rating.
HSBC (NYSE:HBC) upgraded Ventas (VTR) from an “underweight” rating to a “neutral” rating. They have a price target of $50.00 on the company, up from $48.00.
Noble Financial upgraded EnerSys (ENS) from a “hold” rating to a “buy” rating.
JPMorgan Chase & Co. (NYSE:JPM) upgraded Westlake Chemical Corp (WLK) from a “neutral” rating to an “overweight” rating.
Ratings on (VTR) (EPM) (EXPE) (GWW) (MUR) Upgraded
Ratings on Ventas (NYSE: VTR), Evolution Petroleum Co. (NYSE: EPM), Expedia, Inc. (NASDAQ: EXPE), W.W. Grainger, Inc. (NYSE: GWW) and Murphy Oil Corp (NYSE: MUR) were upgraded by analysts.
Robert W. Baird upgraded Ventas (VTR) from an “underperform” rating to a “neutral” rating. They have a price target of $50.00 on the company, up from $48.00.
Global Hunter Securities upgraded Evolution Petroleum Co. (EPM) to a “buy” rating. They have a price target of $12.50 on the company.
Lazard Capital upgraded Expedia, Inc. (EXPE) from a “neutral” rating to a “buy” rating. They have a price target of $30.00 on the company.
Citigroup (NYSE:C) upgraded W.W. Grainger, Inc. (GWW) from a “sell” rating to a “hold” rating.
Raymond James upgraded Murphy Oil Corp (MUR) from a “market perform” rating to an “outperform” rating.
Robert W. Baird upgraded Ventas (VTR) from an “underperform” rating to a “neutral” rating. They have a price target of $50.00 on the company, up from $48.00.
Global Hunter Securities upgraded Evolution Petroleum Co. (EPM) to a “buy” rating. They have a price target of $12.50 on the company.
Lazard Capital upgraded Expedia, Inc. (EXPE) from a “neutral” rating to a “buy” rating. They have a price target of $30.00 on the company.
Citigroup (NYSE:C) upgraded W.W. Grainger, Inc. (GWW) from a “sell” rating to a “hold” rating.
Raymond James upgraded Murphy Oil Corp (MUR) from a “market perform” rating to an “outperform” rating.
Wednesday, May 11, 2011
Ratings on (SCGLY) (SYK) (TNB) (VTR) Upgraded
Ratings on shares of Societe Generale SA (NASDAQ: SCGLY), Stryker (NYSE: SYK), Thomas & Betts Co. (NYSE: TNB) and Ventas (NYSE: VTR) were upgraded by analysts.
RBS upgraded Societe Generale SA (SCGLY) from a “sell” rating to a “hold” rating.
Goldman Sachs (NYSE:GS) upgraded Stryker (SYK) from a “neutral” rating to a “buy” rating.
Bank of America (NYSE:BAC) upgraded Thomas & Betts Co. (TNB) from a “neutral” rating to a “buy” rating. They have a price target of $68.00 on the company.
Stifel Nicolaus upgraded Ventas (VTR) from a “hold” rating to a “buy” rating. They now have a price target of $60.00 on the company.
RBS upgraded Societe Generale SA (SCGLY) from a “sell” rating to a “hold” rating.
Goldman Sachs (NYSE:GS) upgraded Stryker (SYK) from a “neutral” rating to a “buy” rating.
Bank of America (NYSE:BAC) upgraded Thomas & Betts Co. (TNB) from a “neutral” rating to a “buy” rating. They have a price target of $68.00 on the company.
Stifel Nicolaus upgraded Ventas (VTR) from a “hold” rating to a “buy” rating. They now have a price target of $60.00 on the company.
Monday, May 9, 2011
Biggest Losers (JLL) (VTR) (HME) (IPCC) (ARAY) on May 6
Among the big, negative movers on Friday, May 6, were Jones Lang Lasalle (JLL), Ventas (VTR), Home Properties (HME), Infinity Property (IPCC) and Accuray Incorporated (ARAY).
Jones Lang Lasalle (JLL) was down $0.94, to close at $98.69, a loss of 0.94 percent.
Ventas (VTR) fell $0.94 on the day to close at $54.54, a loss of 1.69 percent.
Home Properties (HME) dropped $0.94 to close at $61.14, a loss of 1.51 percent.
Infinity Property (IPCC) declined $0.92 to close the session at $53.47, a loss of 1.69 percent.
Accuray Incorporated (ARAY) plunged $0.92 to end the day at $7.98, a loss of 10.34 percent.
Jones Lang Lasalle (JLL) was down $0.94, to close at $98.69, a loss of 0.94 percent.
Ventas (VTR) fell $0.94 on the day to close at $54.54, a loss of 1.69 percent.
Home Properties (HME) dropped $0.94 to close at $61.14, a loss of 1.51 percent.
Infinity Property (IPCC) declined $0.92 to close the session at $53.47, a loss of 1.69 percent.
Accuray Incorporated (ARAY) plunged $0.92 to end the day at $7.98, a loss of 10.34 percent.
Tuesday, May 3, 2011
Health Care REIT (NYSE:HCN) Misses on Earnings
Health Care REIT (NYSE:HCN) missed in its quarterly earnings by 3 cents a share, generating 70 cents a diluted share, down from 75 cents a diluted share. Analysts had been looking for 73 cents a share.
Revenue came in at $255 million for the quarter.
“Health Care REIT remains on target to deliver strong 2011 earnings growth of 8-11%,” commented George L. Chapman, Health Care REIT’s Chairman, Chief Executive Officer and President. “We recently closed the Genesis HealthCare and Benchmark Senior Living transactions on or ahead of schedule. These closings allowed us to recently raise our 2011 FFO guidance by seven cents as these transactions will be immediately accretive to earnings. The $7 billion of new partnerships formed in 2010 and 2011-to-date demonstrates the successful execution of our relationship investment strategy and positions the company for a strong period of earnings and dividend growth over the next several years,” said Health Care leadership.
Major competitors of Health Care REIT include Nationwide Health Properties Inc. (NYSE:NHP), HCP, Inc. (NYSE:HCP), Ventas, Inc. (NYSE:VTR), Universal Health Realty Income Trust (NYSE:UHT), Omega Healthcare Investors, Inc. (NYSE:OHI), National Health Investors Inc (NYSE:NHI), LTC Properties, Inc. (NYSE:LTC), Senior Housing Properties Trust (NYSE:SNH), Healthcare Realty Trust Inc. (NYSE:HR) and Medical Properties Trust, Inc. (NYSE:MPW)
Health Care Reit was trading at $53.05, falling $1.01, or 1.87 percent, as of 12:21 PM EDT.
Revenue came in at $255 million for the quarter.
“Health Care REIT remains on target to deliver strong 2011 earnings growth of 8-11%,” commented George L. Chapman, Health Care REIT’s Chairman, Chief Executive Officer and President. “We recently closed the Genesis HealthCare and Benchmark Senior Living transactions on or ahead of schedule. These closings allowed us to recently raise our 2011 FFO guidance by seven cents as these transactions will be immediately accretive to earnings. The $7 billion of new partnerships formed in 2010 and 2011-to-date demonstrates the successful execution of our relationship investment strategy and positions the company for a strong period of earnings and dividend growth over the next several years,” said Health Care leadership.
Major competitors of Health Care REIT include Nationwide Health Properties Inc. (NYSE:NHP), HCP, Inc. (NYSE:HCP), Ventas, Inc. (NYSE:VTR), Universal Health Realty Income Trust (NYSE:UHT), Omega Healthcare Investors, Inc. (NYSE:OHI), National Health Investors Inc (NYSE:NHI), LTC Properties, Inc. (NYSE:LTC), Senior Housing Properties Trust (NYSE:SNH), Healthcare Realty Trust Inc. (NYSE:HR) and Medical Properties Trust, Inc. (NYSE:MPW)
Health Care Reit was trading at $53.05, falling $1.01, or 1.87 percent, as of 12:21 PM EDT.
Subscribe to:
Posts (Atom)